Study details tactics used to thwart generic inhalers; report cites 'urgent' need for more diverse clinical trials

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT+: Drugmakers use monopoly tactics to thwart lower-cost generic competition for inhalers, analysis finds By Ed Silverman Adobe "More robust generic competition is critical ... as high prices remain a key barrier to treatment," said study co-author William Feldman. Read More National Academies report cites 'urgent' need to recruit more diverse participants for clinical trials By Usha Lee McFarling Adobe The authors said funding to include and recruit more diverse participants for clinical trials should be a priority that is enforced. Read More STAT+: High blood pressure pills are costly — but also hard to find — in some lower-income countries By Ed Silverman APStock The ability to control blood pressure, a risk factor for the leading cause of death worldwide, is being hindered, a new report finds. Read More Sponsor content by Biotechnology Innovation Organization (BIO) BIO International Convention 2022 Biotech brought the world back from the brink. Now we can get together to celebrate, build on your accomplishments, and make the impossible possible. Endless opportunities to share, partner, and learn. Join us in person, June 13-16 in San Diego for the BIO International Convention 2022. What happens when the government stops buying Covid-19 vaccines? By Rachel Cohrs Virginia Mayo/AP The federal government has distributed Covid-19 vaccines and treatments for free so far, but most likely, the handouts won't last forever. Read More FDA clears Covid booster shot for healthy kids ages 5 to 11 By Lauran Neergaard — Associated Press Rogelio V. Solis/AP Pfizer's shot is the only Covid vaccine available for U.S. kids. Those 5 to 11 receive one-third of the dose given to everyone 12 and older. Read More Tuesday, May 17, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser